Dr. Amber Bhatnagar

Webinar on Tolvaptan ” Hyponatremia And The Emerging Role of Tolvaptan in Cardiology “

May 30, 2022

Tolvaptan

Tolvarise Webinar

by Dr. Amber Bhatnagar, MD, DM (Cardiology), Consultant Cardiologist, Shri Ram Hospital, Jodhpur

View webinar details

Tolvaptan Tolvarise Webinar

Webinar on Tolvaptan ” Hyponatremia And The Emerging Role of Tolvaptan in Cardiology “

Dr. Amber Bhatnagar

30/05/2022 8:00 pm

Topic: "Hyponatremia And The Emerging Role of Tolvaptan in Cardiology"

Date: 30th May 2022
Time- 8:00 PM Onwards

ZOOM Meet Link- https://us02web.zoom.us/j/84402344024
Meeting ID- 844 0234 4024
Passcode: tolvarise

May 30, 2022

Recent webinars

mexelitine Welhart Webinar

Webinar on Mexiletine #21: An Unexplored Antiarrhythmic Drug

Dr. Adeel Majid Belim

Go to youtube

May 20, 2022

mexelitine Welhart Webinar

Webinar on Mexiletine #20: An Unexplored Antiarrhythmic Drug

by Dr Ashish Badkhal,

Go to youtube

January 31, 2022

mexelitine Welhart Webinar

Webinar on Mexiletine #19: An Unexplored Antiarrhythmic Drug

Dr .Johann Christopher

Go to youtube

January 12, 2022

mexelitine Welhart Webinar

Webinar on Mexiletine #18: An Unexplored Antiarrhythmic Drug

Dr. Husain Bhatia

Go to youtube

December 25, 2021

mexelitine Welhart Webinar

Webinar on Mexiletine #17: An Unexplored Antiarrhythmic Drug

Dr. Hiren Kevadiya Patel

Go to youtube

December 23, 2021

mexelitine Welhart Webinar

Webinar on Mexiletine #16: An Unexplored Antiarrhythmic Drug

Dr. Akhil Sharma

Go to youtube

December 21, 2021

mexelitine Welhart Webinar

Webinar on Mexiletine #15: An Unexplored Antiarrhythmic Drug

Dr. K. KIRAN KUMAR

Go to youtube

December 18, 2021

mexelitine Welhart Webinar

Webinar on Mexiletine #14: An Unexplored Antiarrhythmic Drug

Dr. Anupam Jena

Go to youtube

November 17, 2021

mexelitine Welhart Webinar

Webinar on Mexiletine #13: An Unexplored Antiarrhythmic Drug

Dr. R.R. Mantri

Go to youtube

November 10, 2021

mexelitine Welhart Webinar

Webinar on Mexiletine #12: An Unexplored Antiarrhythmic Drug

Dr. Mehraj Ud Din Shah

Go to youtube

October 27, 2021

mexelitine Welhart Webinar

Webinar on Mexiletine #11: An Unexplored Antiarrhythmic Drug

Dr. Sukriti Bhalla

Go to youtube

October 21, 2021

mexelitine Welhart Webinar

Webinar on Mexiletine #10: An Unexplored Antiarrhythmic Drug

Dr. Ashwani Mehta

Go to youtube

October 14, 2021

mexelitine Welhart Webinar

Webinar on Mexiletine #9: An Unexplored Antiarrhythmic Drug

Dr (Col) Viney Jetley

Go to youtube

October 12, 2021

mexelitine Welhart Webinar

Webinar on Mexiletine #8: An Unexplored Antiarrhythmic Drug

Dr. Satbir Singh

Go to youtube

October 6, 2021

mexelitine Welhart Webinar

Webinar on Mexiletine #7: An Unexplored Antiarrhythmic Drug

Dr. R.D. Yadave

Go to youtube

September 30, 2021

mexelitine Welhart Webinar

Webinar on Mexiletine #6 : An Unexplored Antiarrhythmic Drug

Dr Devendra Sharma

Go to youtube

September 24, 2021

mexelitine Welhart Webinar

Webinar on Mexiletine #5 : An Unexplored Antiarrhythmic Drug

Dr Sanjeev Mittal

Go to youtube

September 4, 2021

mexelitine Welhart Webinar

Webinar on Mexiletine #4 : An Unexplored Antiarrhythmic Drug

Dr. Rajeev Marwaha

Go to youtube

July 24, 2021

mexelitine Welhart Webinar

Webinar on Mexiletine #3 : An Unexplored Antiarrhythmic Drug

Dr Pankaj Manoria

Go to youtube

June 30, 2021

mexelitine Welhart Webinar

Webinar on Mexiletine #2 : An Unexplored Antiarrhythmic Drug

Dr Aniruddha Vyas

Go to youtube

June 28, 2021

mexelitine Welhart Webinar

Webinar on Mexiletine #1: An Unexplored Antiarrhythmic Drug

Dr Chetan Rathi

Go to youtube

June 18, 2021

Title of the webinar

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Condimentum diam orci pretium a pharetra, feugiat cursus. Dictumst risus, sem egestas odio cras adipiscing vulputate. Nisi, risus in suscipit non. Non commodo volutpat, pharetra, vel. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Condimentum diam orci pretium a pharetra, feugiat cursus. Dictumst risus, sem egestas odio cras adipiscing vulputate. Nisi, risus in suscipit non. Non commodo volutpat, pharetra, vel.